On July 28 , according to the World Health Organization is World Hepatitis Day, to raise awareness and knowledge about the problem of viral hepatitis. This work has been carried out since 2008 as part of a global strategy for the elimination of viral hepatitis as a public health problem.
But the problem of viral hepatitis in the world remains important. In the (WHO Global hepatitis report, 2017), it is estimated that 325 million people worldwide are living with a chronic infection caused by the hepatitis B virus (HBV) or hepatitis C virus (HCV). Viral hepatitis causes acute and chronic liver disease, killing nearly 1.5 million people annually. Most of these cases are associated with hepatitis B and C (according to WHO).
According to Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the incidence of hepatitis in Russia remains consistently high. Only in April 2017, about 1,100 people became infected. But there is no objective data on the number of Russians with hepatitis in Russia, stated by Irina Shestakova, specialist of the Russian Ministry of Health for Infectious Diseases, at a July 25, 2017 press conference.
The main problem with Hepatitis C is the diagnosis. According to the head of the Infectious Diseases Department of the Russian Medical Academy of Postgraduate Education (RMAPE) Natalia Belyaeva, almost 75% of people have asymptomatic disease, when people do not even suspect that they are ill, there are no typical symptoms of hepatitis. And today, according to WHO, only one in 20 infected people knows about their illness. Identify the disease can be only through diagnostic tests.
"InterLabService " company provides clinics with equipment and kits for hepatitis viruses diagnosis. The company offers data on the infected number and the disease diagnosis problems in various regions of the Russian Federation.
According to Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing for January-June 2017, compared with the same period in 2016, the Russian Federation registered a decrease in incidence of acute hepatitis B virus by 7.8% and chronic hepatitis B by 6.6%. At the same time, the incidence of acute hepatitis A increased two fold and acute hepatitis E increased by 44.1%.
The incidence of acute hepatitis A increased 2 times, and was 3.7 per 100 thousand of the population, compared to 1.9 in January-June 2016. High incidence rates were recorded in the Penza region (9.1 per 100,000 population), the Udmurt Republic (8,3), Irkutsk (7,5), Ivanovo regions (7,4), Perm Krai (6,9), Novosibirsk (6,8), Kaluga (6,5), Kostroma regions (6,0) , St. Petersburg (6.0), Kaliningrad (5.9), Samara (5.8) regions.
The company "InterLabService" offers a comprehensive approach in providing supplies, equipment and kits for detection of hepatitis A, B, C, D G and HIV infections. The highest quality of products is ensured by Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance, Moscow, on its basis high technological production was established.
AmpliSens kits contain the necessary controls for all stages of analysis, having high analytical sensitivity and specificity, and are adapted to most of the amplifiers used.
Due to their high quality and competitive cost, AmpliSens reagents are used by government institutions such as blood services, AIDS centers, hygiene and epidemiology centers, and commercial laboratories for over 10 years.
In 2017, the theme of World Hepatitis Day is "Eliminate Hepatitis". WHO developed the "Global Health Sector Strategy for Viral Hepatitis", which aims to provide 90% testing and treatment for 80% of people with HBV and HCV by 2030.
The company "InterLabService" calls on all people to be tested once a year, to be informed about the hepatitis problem. A timely examination can save your life!